John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cloudflare
NET
|
+$299M |
| 2 |
Advanced Micro Devices
AMD
|
+$249M |
| 3 |
Pfizer
PFE
|
+$227M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$212M |
| 5 |
NVIDIA
NVDA
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$241M |
| 2 |
Cisco
CSCO
|
+$234M |
| 3 |
Analog Devices
ADI
|
+$198M |
| 4 |
Mondelez International
MDLZ
|
+$185M |
| 5 |
Philip Morris
PM
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.01% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 10.3% |
| 4 | Industrials | 9.92% |
| 5 | Financials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
CarParts.com
PRTS
$49M
| $127K | ﹤0.01% |
+1,130
| New | +$156K |
|
|
SLNO
4002
DELISTED
Soleno Therapeutics
SLNO
| $127K | ﹤0.01% |
20,636
-3,754
| -15% | -$39.4K |
|
4003
Bolt Biotherapeutics
BOLT
$7.42M
| $125K | ﹤0.01% |
+1,275
| New | +$242K |
|
|
XNET
4004
Xunlei
XNET
$323M
| $125K | ﹤0.01% |
62,111
+42,002
| +209% | +$110K |
|
|
APTX
4005
DELISTED
Aptinyx Inc. Common Stock
APTX
| $123K | ﹤0.01% |
46,102
+24,202
| +111% | +$58.2K |
|
|
MF
4006
DELISTED
Missfresh Limited American Depositary Shares
MF
| $123K | ﹤0.01% |
+818
| New | +$105K |
|
|
UXIN
4007
Uxin Ltd
UXIN
$260M
| $122K | ﹤0.01% |
+771
| New | +$166K |
|
4008
Innodata
INOD
$1.97B
| $121K | ﹤0.01% |
+20,521
| New | +$167K |
|
|
PR
4009
PUT
Permian Resources
PR
$19.5B
| $119K | ﹤0.01% |
19,900
+5,200
| +35% | +$35.4K |
|
4010
CALL
Sabre
SABR
$912M
| $119K | ﹤0.01% |
13,900
-170,200
| -92% | -$1.63M |
|
4011
Tidewater
TDW
$4.59B
| $119K | ﹤0.01% |
11,124
-24,040
| -68% | -$282K |
|
4012
Worksport
WKSP
$7.49M
| $119K | ﹤0.01% |
+4,930
| New | +$221K |
|
4013
Wave Life Sciences
WVE
$1.03B
| $119K | ﹤0.01% |
+37,898
| New | +$157K |
|
4014
CALL
Angi Inc
ANGI
$200M
| $118K | ﹤0.01% |
+1,280
| New | +$138K |
|
4015
Asure Software
ASUR
$249M
| $118K | ﹤0.01% |
15,077
-12,090
| -45% | -$106K |
|
4016
Grupo Aval
AVAL
$6.58B
| $118K | ﹤0.01% |
23,150
-268,952
| -92% | -$1.51M |
|
4017
CALL
Comstock Resources
CRK
$4.16B
| $118K | ﹤0.01% |
+14,600
| New | +$133K |
|
4018
CALL
Frontline
FRO
$9.68B
| $118K | ﹤0.01% |
+16,700
| New | +$133K |
|
4019
Ultralife
ULBI
$110M
| $118K | ﹤0.01% |
+19,517
| New | +$120K |
|
4020
Marchex
MCHX
$79.8M
| $117K | ﹤0.01% |
47,016
-12,535
| -21% | -$36.4K |
|
|
EFTR
4021
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $117K | ﹤0.01% |
+565
| New | +$131K |
|
4022
PUT
FuelCell Energy
FCEL
$1.54B
| $116K | ﹤0.01% |
743
-84
| -10% | -$19.8K |
|
|
ASPU
4023
DELISTED
ASPEN GROUP, INC.
ASPU
| $116K | ﹤0.01% |
+48,982
| New | +$200K |
|
|
MOMO
4024
CALL
Hello Group
MOMO
$853M
| $115K | ﹤0.01% |
12,800
-93,600
| -88% | -$1.07M |
|
4025
PUT
Microvision
MVIS
$55.4M
| $115K | ﹤0.01% |
1,527
-19,906
| -93% | -$2.38M |
|
Similar funds
John Overdeck's Q4 2021 Portfolio in Review
As of Q4 2021, John Overdeck held 5,171 positions worth $46.8B, up 4.6% from $44.7B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
John Overdeck's Q4 2021 filing shows 995 new, 1,525 increased, 1,628 reduced and 977 closed positions. Its largest new stake was Cloudflare: 1,781,661 shares worth $234M. The largest sale was Lam Research, an estimated $241M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- John Overdeck's largest Q4 2021 buy was Cloudflare: 1,781,661 shares worth $234M.
- John Overdeck added most to Advanced Micro Devices in Q4 2021, an estimated $249M increase.
- John Overdeck's biggest Q4 2021 reduction was Mondelez International, cutting an estimated $185M.
- John Overdeck fully exited Lam Research in Q4 2021, selling an estimated $241M.
- John Overdeck's ten largest holdings make up 5.7% of its $46.8B portfolio in Q4 2021.
- John Overdeck opened 995 new positions and closed 977 in Q4 2021.
- John Overdeck's portfolio value rose 4.6% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.